GP20 is a consulting division that helps pharmaceutical clients challenge the status quo. It provides portfolio optimization and strategy consulting, market entry planning and implementation support, and project management services. GP20's experienced team of professionals leverage their regulatory and technical expertise to help clients capitalize on opportunities across the generics/biosimilars industry.

1. Challenge the status quo
CONSULTING DIVISION

2. about usThought leaders and experienced
professionals combine to help clients
challenge the status quo in the
pharmaceutical industry.
1|

3. a little bit of backgroundWe started out in 2008 as a spin
out of the renowned regulatory
and technical services provider
in the UK, ICE Pharma Group,
founded in the mid 90s. Since
2008 we have launched several
on-line platforms, which have
opened a rich dialogue with
an international community of
C-level executives and decision
makers around the globe.
Our first platform,
Genericlicensing.com was
the industry’s first searchable
database of dossiers – with
8,000+ products, reaching
hundreds of product developers
and licensing teams. GP20 also
launched NewPharmaThinkers,
a digital magazine that today
inspires key thought leaders in
our industry.
These innovative
communication and data
platforms have helped create an
unparalleled industry network;
supporting an unique channel
for new opportunities and ideas.
Together with a solid industry
background of over 15 years,
GP20 is ideally positioned to
bring you specialised consulting
services.
2|

4. management team
Asa Cox
Asa has been involved in the generic
pharmaceutical industry for
15 years; his work experience
covers both technical and
commercial aspects of the
industry. Sourcing, finished dose
contract manufacturing, regulatory
approvals and formulation development. He also
has extensive experience in negotiating global
licensing deals with all the major players.
Asa has worked on projects for Merck & Co,
Sanofi, Teva, Apotex, Reckitt Benckiser, Sandoz &
many more.
Miguel Coronado
Miguel has over 8 years international
experience both in technical and
commercial roles within the pharma
industry. He has provided strategic
consulting to pharmaceutical
companies in Europe, LATAM
and MENA regions with specialized
expertise in Strategy, Market Entry and Portfolio
Management in generics.
Miguel holds a Master degree in Pharmacy and is a
fellow member of RPSGB.
3|

5. GP20 divisions
Business
Development
Agency
Management
Consulting Marketing Digital
Platforms
• GENERICS & BIOSIMILARS
• OVER THE COUNTER
• MEDICAL DEVICES
• PORTFOLIO STRATEGY
• MARKET ENTRY
• PROJECT MANAGEMENT
• ON-LINE MARKETING
• WEB & PRINT DESIGN
• LEAD GENERATION
• GENERIC LICENSING
• NEW PHARMA THINKERS
• GENERIC PHARMA INDUSTRY
4|

6. Whether you require optimisation your
current portfolio or plan your next market
entry move, GP20 can definitely assist.
our consulting division

7. DEDICATION
We help companies capitalize on
opportunities across the value
chain for generics, branded
generics and biosimilars, forging
connections among industry
stakeholders.
EXPERTISE
Our work has covered a wide
range of topics, including portfolio
optimization, market entry,
operations, corporate strategy,
regulatory affairs and due diligence.
PASSION
Our people bring new ideas, inspiration, and
dedication to help you succeed in the pharmaceutical
field. We are passionate about the possibilities ahead
for those that challenge the status quo today and are
pleased to work with all participants in the generics
industry, API manufacturers, specialty pharmaceutical,
and private-equity players.
6|
what can we do for you?

8. our consulting division
We offer broad experience and deep expertise in three key areas:
7|
PORTFOLIO OPTIMIZATION
& STRATEGY
Experience in industry best
practice to help you integrate and
implement portfolio strategy across
the organisation. Implementing
best practice in portfolio strategy
requires more than market data and
profit & loss analysis. We believe that
without an integrated vision across
the organisation successful portfolio
strategy is extremely challenging.
MARKET ENTRY PLANNING AND
IMPLEMENTATION
We apply our understanding of
the pharmaceutical industry on
international and regional markets
to develop long-term perspectives
that help clients achieve sustained
competitive advantage in target
regions.
PROJECT MANAGEMENT
GP20’s project management
expertise is applied to maximize
of shareholder value, as well as to
opportunities in M&A due diligence
and licensing. We work with clients to
transform their companies, improve
effectiveness, increase productivity,
and build new capabilities. Our
experience in technical and
commercial project management
means you can focus on your core
activities.

9. portfolio optimization
and strategy
We believe that planning and decision making must be aligned and
integrated with all divisions involved in portfolio development. At GP20
we can help you create a living framework that enables stakeholders
communicate efficiently at all stages of portfolio processing.
OUR PROPRIETARY FRAMEWORK
HELPS YOUR ORGANIZATION ON:
• Portfolio planning process globally
• Data capture
• Communication approach between
stakeholders
• Portfolio optimisation tools
• Risk management
• Guidance and training material
ARE INNOVATION AND CONTINUOUS
IMPROVEMENT INGRAINED AT THE CORE
OF YOUR COMPANY?
Whether you are planning the development
of high quality generics, biosimilars or
new molecular entities into new markets,
achieving operational excellence is a key
factor to succeed in the long run. Here
are a few hints that will help you avoiding
portfolio disaster across a single or multi-
country market approach.
• The company strategy must drive the
portfolio
• Horizontal integration in relation to the
portfolio presents interesting upsides
• Consider the implementation of a
dedicated cross-functional portfolio team
• Establish an integrated platform
that monitors all divisions in your
organisation closely.

10. market entry planning
and implementation
At GP20 we share our experience for mitigating the risks inherent in
entering any new market, helping achieve desired outcomes in the most
cost effective way possible.
OUR PROPRIETARY FRAMEWORK HELPS YOUR
ORGANIZATION ON:
• Analysis: identifying the entry option and validating
target market
• Planning: assembling a coherent market entry strategy
and implementation plan
• Implementation: pilot project
• Operations: business set up, marketing launch, recruitment
• Communication approach between stakeholders
• Risk management
HAVE YOU PERFORMED
A PROPER MARKET
VALIDATION TO VERIFY
YOUR PLAN WILL
WORK?
We would like to share
with you a few points
when considering market
validation.
• Assess the resources and capabilities
required for different scenarios
• Validate your market entry portfolio from
a cross-functional point of view
• Validate your pricing strategy
• Evaluate the ability to completely address
the need, making sure your portfolio
and associated procedures will satisfy
customers and stakeholders

11. project management
The right mix of planning, monitoring, and controlling can make the
difference in completing a project on time, on budget, and with high
quality results.
OUR PROPRIETARY FRAMEWORK HELPS YOUR
ORGANIZATION ON:
• Identify strategic options: GP20 brings clarity to the
project goals, aligned to a detailed understanding of
your business needs
• Project definition and planning: we design a rigorous
programme, including team roles and responsibilities,
identifying risk and saving opportunities
• Project execution: we act quickly, operating from
within the organisation and working harmoniously
with your company culture
• Project closure: we aim to deliver to the satisfaction
of all stakeholders, demonstrating real value in both
quantitative and qualitative terms
Our project management experts offer a flexible and highly bespoke
service based on a strong focus on delivery. Working alongside our clients,
GP20 adopts a value-driven approach to defining project objectives.
Regardless the scale or complexity of a project, we refine our systems and
processes to provide control, governance and transparency from inception
to completion. At the point of every decision, we challenge the status
quo and work diligently to find the smartest, most efficient and most cost
effective solution.
GP20 provides a full spectrum of project management services
along all functions of the value chain in pharmaceuticals, including
manufacturing, supply chain, regulatory affairs, quality compliance,
and commercial operations.

12. We are delighted to share some examples of
our work and what clients say about us.
examples of our work

13. Assessing a hospital portfolio
for Central Europe
CASE STUDY / PORTFOLIO STRATEGY
Challenge
A leading generics manufacturer wanted to leverage
one of their injectable facilities to build a hospital
portfolio targeting simultaneously several countries
in Central Europe. The company was facing certain
complexities to align their internal resources and
capabilities with a commercially attractive portfolio on
a multi-country level.
Outcome
The final portfolio proposed by the GP20 team was agreed and accepted by the executive management and core
divisions. The client now has an optimal portfolio and associated guideline for introduction, which allows full
visibility across market entry implementation processes.
Solution
GP20 assessed the portfolio opportunities in the hospital sector and the
entry requirements for the targeted regions. GP20 conducted extensive
research that answered essential questions regarding the portfolio
options and what approach would truly succeed as a value proposition.
Our consultants and Subject Matter Experts worked with the client to
define several approaches and associated risks/benefits for the portfolio
across the targeted regions and facilitated a set of recommendations.

14. Helping a regional player
obtaining EU GMP standards
CASE STUDY / PROJECT MANAGEMENT
Challenge
A pharmaceutical distribution company with operations
in MENA engaged GP20 to handle all its technical and
regulatory processes in Europe, including the production
of a Quality Management System suitable for obtaining
EU GMP certificate. At the time the client had no
consistent QMS framework in place and ownership of
SOPs and other process documents was unclear.
Outcome
The client is now able to demonstrate a coherent quality and compliance infrastructure to its clients and other
stakeholders in MENA region. The integrated project management service supported the production of a coherent
QMS framework and helped the organization focus on their core activities.
Solution
The GP20 team provided a fully integrated project management and
planning support handling all aspects of quality assurance and regulatory
affairs. We helped designing a set of SOPs that supported the new Quality
Management System of the organization and provided liaison with
regulatory agencies in Europe for obtaining GMPc.

15. a selecton of our clients
We are proud to have worked with fantastic companies in the last decade
Medical Brands
Maikel Hendriks, CEO
We have been working with the
GP20 team for many successful
years. The company has grown
fourfold in this time, with Asa and his
colleagues contributing significantly
in all aspects of the business. We
have secured major clients purely
because of the good relationships
GP20 has developed with them.
“ “ “
Marz Sprays
Brandon Marz, CEO
We have been very happy with
Generic Pharma 2.0’s work. They’re
professional, efficient and get
done what they say they will get
done. They’ve helped us set up our
CRM and Business Development
processes/templates. They’ve
helped guide us through the
process of International Sales
making it a lot easier! They’ve also
provided us access to decision
makers while orchestrating a
follow-up system for our leads.
Resolute Oncology
David Guy, CEO
Generic Pharma 2.0 have been an
extremely valuable partner with the
building of our business, the team’s
experience in the generic business
and his wealth of connections have
helped us at every step.

16. Let’s Talk
We look very much forward to hearing
from you soon.
Asa Cox
asa.cox@genericpharma20.com
Miguel Coronado
miguel.coronado@genericpharma20.com
Offices
UK 96 Kensington High Street
London
W8 4SG
CANADA 12 Dunlop Street
Barrie, Ontario
L4M 1A3
You can also find us at:
www.genericpharma20.com